Given that the critical role of Gemin3 in cancer development, prompted us to speculate that high throughput screening of helicase inhibitors would result in prospective therapeutic strategy against EBV associated B-cell lymphomas possibly through initiating p53 regulated apoptosis. This evidence concerns the gene TP53 and B-cell non-Hodgkin lymphoma.